NCT07150754

Cardiological Drug Classes And Falls in Older Adults

Heart Failure Pharmacological Treatments and Falls in Older Adults: A Disproportionality Analysis of the WHO Pharmacovigilance Database

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 100,000 (actual)
• Sponsor: University Hospital, Caen · Academic / Other
• Sex: All
• Age: 65 Years
• Healthy volunteers: —

Summary

Heat failure is a fast gowing health issue with a rising incidence in older adults. Recommendations have recently been published to treat heart failure, but most clinical trials leading to these recommendations tended to exclude older adults. Older adults are at higher risk of falls and severe consequences of falls. All heart failure treatments are at risk of causing a fall through different mechanisms. Based on the World Health Organization global database, the main objective of this study is to investigate the association between heart failure pharmacological treatments and the report of a fall in the database. A disproportionality analysis will be performed. It will aim to assess whether some classes of heart failure drugs, and within these classes some individual drugs, are associated with a report of a fall. A sensibilty analysis will also be performed. It will aim to examine the association between takien a heart failure pharmacological treatment, with a heat failure indication and/or a loop diuretic, and the report of a fall.

Conditions

• Heart Failure
• Fall

Interventions

Type	Name	Description
DRUG	Heart failure pharmacological treatments	Identify a positive signal for fall with one or more of the recommended pharmacological treatments for heart failure

Timeline

• Start date: 2024-11-02
• Primary completion: 2025-04-01
• Completion: 2025-07-01
• First posted: 2025-09-02
• Last updated: 2025-09-02

Locations

1 site across 1 country: France